Related references
Note: Only part of the references are listed.The Encephalitogenic, Human Myelin Oligodendrocyte Glycoprotein-Induced Antibody Repertoire Is Directed toward Multiple Epitopes in C57BL/6-Immunized Mice
Pankaj Bansal et al.
JOURNAL OF IMMUNOLOGY (2013)
Pathology of Demyelinating Diseases
Bogdan F. Gh. Popescu et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 7 (2012)
Rituximab combination therapy in relapsing multiple sclerosis
Anne H. Cross et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2012)
Neonatal Fc Receptor Blockade by Fc Engineering Ameliorates Arthritis in a Murine Model
Dipesh A. Patel et al.
JOURNAL OF IMMUNOLOGY (2011)
Mechanisms of action of intravenous immunoglobulins
Anne Baerenwaldt et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2010)
Neonatal Fc Receptor: From Immunity to Therapeutics
Timothy T. Kuo et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2010)
Rituximab specifically depletes short-lived autoreactive plasma cells in a mouse model of inflammatory arthritis
Haochu Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Analyses of the Recycling Receptor, FcRn, in Live Cells Reveal Novel Pathways for Lysosomal Delivery
Zhuo Gan et al.
TRAFFIC (2009)
B-cell depletion with Rituximab in relapsing-remitting multiple sclerosis
Stephen L. Hauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Reduction of IgG in nonhuman primates by a peptide antagonist of the neonatal Fc receptor FcRn
Adam R. Mezo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Treatment and treatment trials in multiple sclerosis
Bernd C. Kieseier et al.
CURRENT OPINION IN NEUROLOGY (2007)
Amelioration of experimental autoimmune myasthenia gravis in rats by neonatal FcR blockade
Liming Liu et al.
JOURNAL OF IMMUNOLOGY (2007)
Feedback regulation of murine autoimmunity via dominant anti-inflammatory effects of interferon gamma
Alfredo Minguela et al.
JOURNAL OF IMMUNOLOGY (2007)
Divergent activities of an engineered antibody in murine and human systems have implications for therapeutic antibodies
Carlos Vaccaro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease
Stefka B. Petkova et al.
INTERNATIONAL IMMUNOLOGY (2006)
Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients
Anne H. Cross et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels
C Vaccaro et al.
NATURE BIOTECHNOLOGY (2005)
Intravenous immunoglobulins in the treatment of relapsing remitting multiple sclerosis - results of a retrospective multicenter observational study over five years
J Haas et al.
MULTIPLE SCLEROSIS JOURNAL (2005)
Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology
CB Marta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Pharmacokinetic effects of 4C9, an anti-FcRn antibody, in rats: implications for the use of FcRn inhibitors for the treatment of humoral autoimmune and alloimmune conditions
KE Getman et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Visualizing the site and dynamics of IgG salvage by the MHC class I-related receptor, FcRn
RJ Ober et al.
JOURNAL OF IMMUNOLOGY (2004)
Structural insights into the antigenicity of myelin oligodendrocyte glycoprotein
C Breithaupt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Accelerated autoantibody clearance by intravenous immunoglobulin therapy: studies in experimental models to determine the magnitude and time course of the effect
WK Bleeker et al.
BLOOD (2001)
Detection of autoreactive T cells in H-2u mice using peptide-MHC multimers
CG Radu et al.
INTERNATIONAL IMMUNOLOGY (2000)
Share Paper
